Fierce Biotech Homepage

China flag
Favicon Fierce Biotech

Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’

Hansoh gave a bullish assessment of China’s biopharma role, arguing that it is “fully transitioning from the ‘follower’ to the ‘frontrunner’ phase.”
Nick Paul Taylor Aug 26, 2026 9:33am
Revolution Medicines booth at ASCO 2026

FDA greenlights RevMed’s pancreatic cancer gamechanger

Aug 26, 2026 11:30am
Akeso

Akeso CEO touts biliary tract win, counters ivonescimab debate

Aug 26, 2026 11:11am
Connection together puzzle pieces Concept of business strategy collaboration

McKesson acquires Maryland CRO for $2.25 billion

Aug 25, 2026 11:22am
Moran Texas House
Favicon Fierce Biotech

Why a congressman says China is 'beating us on our ground game'

Aug 25, 2026 9:45am
Heidi Overton
Favicon Fierce Biotech

Trump taps White House aide as next FDA commissioner

Aug 19, 2026 10:17am
More News

ITM cancer drug spurned by FDA over manufacturing qualms

Aug 10, 2026 11:25am

Novo’s Catalent plant ditched in FDA refiling of SMA drug

Aug 10, 2026 10:06am
Fierce Biotech

Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth

Aug 7, 2026 9:08am

Narcan maker Emergent axes top R&D post in sweeping restructuring

Aug 5, 2026 8:16pm